Foresite Capital Management Iii, LLC has filed its 13F form on November 14, 2022 for Q3 2022 where it was disclosed a total value porftolio of $37.9 Million distributed in 4 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ascendis Pharma A/S with a value of $13.8M, Verona Pharma PLC with a value of $11.4M, Natera, Inc. with a value of $6.97M, and Cyma Bay Therapeutics, Inc. with a value of $5.75M.

Examining the 13F form we can see an increase of $10.3M in the current position value, from $27.6M to 37.9M.

Foresite Capital Management Iii, LLC is based out at Larkspur, CA

Below you can find more details about Foresite Capital Management Iii, LLC portfolio as well as his latest detailed transactions.

Portfolio value $37.9 Million
Healthcare: $37.9 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 4
  • Current Value $37.9 Million
  • Prior Value $27.6 Million
  • Filing
  • Period Q3 2022
  • Filing Date November 14, 2022
  • Form Type 13F-HR
  • Activity in Q3 2022
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Foresite Capital Management Iii, LLC Portfolio

Follow Foresite Capital Management Iii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management Iii, LLC with notifications on news.